Obsessive Compulsive DisorderAMP-OCDNCT02114918
Attention Training for Childhood Obsessive Compulsive Disorder
A study testing Attention Modification Program in people with Obsessive Compulsive Disorder, run by University of California, Los Angeles at 1 site in United States.
Trial summary
Voluntary and involuntary attention processes are thought to play an important role in the development and maintenance of anxiety disorders including OCD. Individuals with OCD pay greater attention to threat information related to their illness and have difficulty shifting their attention from such triggers. Read more about this study
- Who is it for?
- Ages 8 to 17 years
- Conditions the study is for
- Obsessive Compulsive Disorder
- What is being tested?
- Attention Modification Program
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 47 participants
- Where
- 1 siteUnited States
- Study dates
- Apr 2013to May 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 8 to 17 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Age 8-17 (inclusive) at the time of initial evaluation
- Subject meets Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) diagnostic criteria for OCD.
- Unmedicated or on stable medication treatment for anxiety, OCD, attention deficit hyperactivity disorder, tics, and/or depressive disorder for at least 6 weeks prior to study entry, with no planned changes for duration of study participation.
- Child is fluent English speaker.
- Parental informed consent and child informed assent must be completed. Parents must agree to their child's participation in this protocol.
Who cannot join
- Intelligence Quotient < 80 on Wechsler Abbreviated Scale of Intelligence (WASI).
- Excessive or problematic substance use as reported per initial telephone screening, or DSM-IV Conduct Disorder within the past 3 months.
- Subject has a lifetime DSM-IV diagnosis of pervasive developmental disorder, Mania, or Psychotic Disorder.
- Subject has any serious psychiatric, psychosocial, or neurological condition (i.e., attention deficit hyperactivity disorder, major depressive disorder, anxiety, anxiety, severe aggression, family discord) requiring immediate treatment other than that provided in the current study.
Trial locations and contacts
1 site in 1 country.
United States1 site
UCLA Semel Institute for Neuroscience and Human Behavior
Los Angeles, California, 90024
About this study
Voluntary and involuntary attention processes are thought to play an important role in the development and maintenance of anxiety disorders including OCD. Individuals with OCD pay greater attention to threat information related to their illness and have difficulty shifting their attention from such triggers. Studies suggest that a change in attention bias may lead to a change in anxiety vulnerability. However, few studies have directly examined the causal role of attention bias in the maintenance of anxiety underlying OCD and whether modification of such biases may reduce pathological anxiety symptoms particularly in children. In this proposal, we aim to translate basic findings from research on cognitive biases in anxiety into a novel computerized intervention for child Obsessive Compulsive Disorder (OCD). The treatment is designed to target a basic cognitive vulnerability in OCD, namely the selective processing of threatening OCD-related information. 52 children with OCD will be randomly assigned to either a 12-session attention modification program (AMP) or an attention control condition (ACC). Clinical assessment of symptom severity along with a brief neurocognitive battery will be conducted before and after treatment. We hypothesize that children in the AMP group at end of treatment will show (1) decreased attention bias to OCD-related triggers using an independent measure of attention bias to assess change and (b) reduced OCD severity. This study is an initial step towards demonstrating the feasibility and efficacy of a novel computerized attention training program for OCD that ultimately may prove to be a highly transportable and accessible intervention for this childhood psychiatric disorder. Furthermore, the project will also examine neurocognitive performance before and after attention training to elucidate possible predictors and mechanisms of treatment response.
Read the detailed description
In this proposal, we aim to translate basic findings from research on cognitive biases in anxiety into a novel computerized intervention for child OCD. The treatment is designed to target a basic cognitive vulnerability in OCD, namely the selective processing of threatening OCD-related information. Briefly, the computerized procedure involves repeatedly redirecting participants' attention away from OCD-relevant threat cues in order to induce selective processing of neutral (non-threat) stimuli. This study is an initial step towards demonstrating the efficacy of a potentially highly transportable and accessible intervention for OCD. Furthermore, the project will also examine neurocognitive performance before and after attention modification to elucidate possible predictors and mechanisms of treatment response.
Aim 1: To examine the preliminary efficacy of a 12-session computerized attention modification program (AMP) on attention bias and symptom severity in children with OCD.
Hypothesis 1a: AMP treatment compared to the attention control condition (ACC) will be associated with a decrease in attention bias towards threat-cues in youth with OCD.
Hypothesis 1b: AMP treatment will be associated with a decrease in OCD symptom severity among OCD youth as measured by clinician-administered diagnostic interview and symptom rating scales.
Aim 2: To examine the changes in neurocognitive status over the course of treatment with AMP in children and adolescents with OCD.
Hypothesis 2: Those children who respond to AMP will exhibit improved performance on relevant neurocognitive measures at post-treatment.
Aim 3: To examine the relationship between baseline neurocognitive status and response to AMP.
Hypothesis 3: Baseline neurocognitive performance will be associated with greater AMP-related improvement in symptom severity among youth with OCD.
Exploratory Aim: To investigate the potential relationship between AMP and changes in behavioral and electrophysiological (EEG) correlates of cognitive control and affect regulation before and after treatment with AMP or ACC. The objective is to examine the feasibility, acceptability and suitability of using Error-Related Negativity (ERN), an evoked response potential (ERP) generated from cognitive activation paradigms assessing action-monitoring and conflict resolution under neutral and emotional contexts, to elucidate potential neural mechanisms underlying treatment. Although not powered for formal tests of mediation, we will explore in a preliminary fashion whether these neural indices may serve as potential biomarkers for pediatric OCD as well as predictors/mediators of treatment response.
Preliminary hypotheses: 1) Youth with OCD will be characterized by high amplitude ERN, which will not change with treatment; 2) AMP treatment will be associated with changes in EEG reflecting greater engagement of top-down (as indexed by the P3 component) versus bottom-up (indexed by the P1/N1 components) neural processes, particularly among children who exhibit improved performance on cognitive control tasks; 3) Baseline executive functioning in interference control and action monitoring will be associated with greater AMP-related improvement in OCD severity; 4) We will also explore the relationships of key variables such as trait anxiety, self-reported attention control, baseline OCD symptom severity and attention bias with each other and with response to AMP.
OCD is a chronic and often disabling psychiatric condition, affecting 2-4% of children and adolescents1. In the absence of effective treatment, it is often associated with considerable social, academic and familial impairment along with considerable psychiatric comorbidity including Tourette's and other Chronic Tic Disorders. Although a number of empirically supported treatments, both behavioral and pharmacological, exist for OCD, many children and their families are either not able to adequately access these treatments or derive only partial benefit from them. Thus, it is of critical importance to expand treatment options and develop more effective treatments that have the potential to be widely accessible to children suffering from OCD.
One etiological model of OCD proposes that symptoms arise from the abnormal processing of threat-relevant information. According to this model, selective attention to threatening information heightens anxiety and anxiety-related avoidance of the perceived threat, and the avoidance behaviors, in turn, prevent disconfirmation of fear-related beliefs and serves to maintain anxiety. Thus, attention bias towards threat may be causally related to the behavioral avoidance of the perceived threat. Research indicates that attention bias towards OCD related material ameliorates after effective cognitive behavioral therapy, thus highlighting that attention bias is malleable. Nevertheless, the critical question remains whether a reduction in attention bias causes a reduction in OCD symptoms or whether attention bias is an epiphenomenon of the symptoms. Recently, studies have begun to directly manipulate attention bias to address this question. In one such study, attention was trained in adults with OCD contamination fears by building a contingency between the locations of the OCD-related word in the active condition and not in the control condition on a modified dot-probe task. Participants in the attention training group showed significant reductions in both attention bias for threat and OCD symptom severity. The extension of this research to clinical patient and child samples with a multi-session treatment protocol has yet to be conducted. To date, no study has investigated attention training in children with OCD, although there are data to suggest positive results in adults with OCD as well as Social Phobia and Generalized Anxiety Disorder.
A number of recent studies have demonstrated that the willful direction of attention in the presence of threatening stimuli activates prefrontal regions thought to be involved in attention control, which in turn appears to down-regulate activation of the amygdala, a structure involved in the emotional processing of fear/threat stimuli. Many of these tasks have involved techniques like cognitive reappraisal or altering cognitive processing of threatening. The question remains whether similar neurobiological mechanisms underlie the effects of attention training. Given the importance of higher-level attention control in reducing biased attention processing and dampening anxious states, helping anxious individuals improve attention control may be an important mechanism for reducing the negative impact and development of psychopathology. In an attempt to gather preliminary data on the possible neurocognitive predictors and mechanisms of treatment response, we also plan to assess aspects of response inhibition and memory/learning that have been implicated in neurocognitive studies of OCD before and after treatment with AMP.
We hypothesize that training attention away from OCD-related threat stimuli will decrease attention bias towards the threat and based on the assumption that attention bias is causally related to anxiety symptoms, this decrease in bias would lead to a decrease in avoidance of threatening stimuli. More specifically, we predict that compared to the control condition (ACC), AMP will decrease attention bias towards the threat and facilitate behavioral approach towards the feared stimuli in children with OCD along with an overall decrease in their symptom severity.
The present study focuses on children and adolescents for two important reasons. First, OCD typically onsets in childhood, and enhanced understanding of the neuro-developmental correlates of OCD and mechanisms underlying treatment at this age has the potential to prevent long-term morbidity. Second, the focus on this age group allows us to study the disorders prior to the development of significant secondary psychiatric and psychosocial morbidity, which commonly accompanies OCD in adulthood. Thus far, only limited research on the effects of attention modification training on OCD severity has been conducted in children. This study may generate significant new information concerning the neurocognitive underpinnings of OCD, the commonality of these underpinnings to other neurodevelopmental disorders of childhood, and the neurocognitive correlates of response to a potentially new and relatively accessible nonpharmacological treatment intervention. This knowledge will be used to develop more effective treatments with an eye towards matching interventions to specific individuals on the basis of characteristic pre-treatment cognitive profiles.
- Conditions
- Obsessive Compulsive Disorder
- Being tested
- Attention Modification Program, Attention Control Condition
- Keywords
- obsessive compulsive disorder, children, adolescents, attention bias modification
- Medical subject headings
- Obsessive-Compulsive Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Attention Modification ProgramBehavioural
Also called AMP, attention bias modification, attention training
Each trial begins with a fixation cross presented in the center of the computer screen for 500 ms. The cross is then replaced by a word pair presented in the center of the screen for 500 ms. The word pair disappears and a probe (i.e., the letter "E" or "F") appears immediately in the location of one of the two words. Participants will be instructed to decide whether the letter is an E or an F and press the corresponding mouse button. This paradigm has been modified to facilitate an attention bias away from threatening material. In this case, the probe always replaces the neutral word. Thus, although there will be no specific instruction to direct attention away from the threat word, on all trials, the position of the neutral word will indicate the position of the probe.
Attention Control ConditionBehavioural
Also called ACC
Each trial begins with a fixation cross presented in the center of the computer screen for 500 ms. The cross is then replaced by a word pair presented in the center of the screen for 500 ms. The word pair disappears and a probe (i.e., the letter "E" or "F") appears immediately in the location of one of the two words. Participants will be instructed to decide whether the letter is an E or an F and press the corresponding mouse button. This paradigm is not intended to facilitate an attention bias away from threatening material. In this case, the probe randomly replaces the threat or neutral word.
| Study group | Role | What they receive |
|---|---|---|
| Attention Modification Program | Experimental | Active computer-based attention training treatment designed to directly but implicitly modify biased attention patterns in anxious patients in service of symptom relief. AMP is a modified version of the dot-probe paradigm similar to the original task used by MacLeod, Mathews, and Tata. This paradigm has been modified to facilitate an attention bias away from threatening material. In this case, the probe always replaces the neutral word. Receives: Behavioral: Attention Modification Program |
| Attention Control Condition | Placebo comparator | Control computer-based attention training task, which is not designed to modify biased attention patterns in anxious patients. ACC is a modified version of the dot-probe paradigm similar to the original task used by MacLeod, Mathews, and Tata. In this case, the probe randomly replaces the neutral word or the threat word. Receives: Behavioral: Attention Control Condition |
What is being measured
The primary outcome is the main question the study is designed to answer.
Clinical Global Impression-Severity (CGI-S) and Improvement (CGI-I) Scales Change From Pre-Treatment to Post-Treatment
Clinical Global Impression-Severity (CGI-S) and Improvement (CGI-I) Scales. The CGI-S and CGI-I are clinician-rated scales used in clinical trials for over 25 years. Participants receiving a post-treatment CGI-I score of 1 (very much improved) or 2 (much improved) on this one-item, 7-point rating will be considered treatment responders.
Measured: pre-treatment (week 0) and post-treatment (week 5)
Secondary outcomes (2)
Children's Yale-Brown Obsessive Compulsive Scale Change From Pre-Treatment to Post-Treatment
Children's Yale Brown Obsessive Compulsive Scale (CYBOCS) is a psychometrically sound, semi-structured clinical interview assessing OCD severity. The measure includes a comprehensive symptom checklist and will be used as one measure of treatment response.
Measured: pre-treatment (week 0) and post-treatment (week 5)
Attention Bias Assessment Change from Pre-Treatment to Post-Treatment
Computerized assessment of attention bias. The classic dot-probe paradigm used in the majority of studies examining attention bias will be adapted for this project. AMP will occur with one set of words (e.g., Set A) and the other word set (Set B) will be used for pre and post-training assessment of attention bias. We plan to use a modified version of the Posner spatial cueing paradigm using 8 OCD-related threat and eight neutral word cues word pairs.
Measured: pre-treatment (week 0) and post-treatment (week 5)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Apr 2014 (estimated)
- Study startApr 2013
- Primary completionJan 2016
- Study completionMay 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Obsessive Compulsive DisorderStudies of the same condition, open and under way.
- More trials run by University of California, Los AngelesThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 47 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of California, Los Angeles
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute of Mental Health (NIMH)
- Responsible party
- Principal investigator, Susanna Chang, PhD, University of California, Los Angeles
- Investigators
- Susanna Chang, PhD, Principal investigator, University of California, Los AngelesJohn Piacentini, PhD, Principal investigator, University of California, Los Angeles
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02114918
- Sponsor's protocol ID
- IRB#11-000195
- Other IDs
- 1R34MH095885-01A1
- Acronym
- AMP-OCD
- Status last verified
- Jan 2017
- First submitted
- 11 Apr 2014
- Last updated
- 16 Jan 2017
- Results posted
- No
- Data monitoring committee
- Yes
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Jan 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Attention Training for Childhood Obsessive Compulsive Disorder
- ClinicalTrials.gov ID
- NCT02114918
- Acronym / sponsor ID
- AMP-OCD / IRB#11-000195
- Conditions
- Obsessive Compulsive Disorder
- Keywords
- obsessive compulsive disorder, children, adolescents, attention bias modification
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 47 participants (actual)
- Lead sponsor
- University of California, Los AngelesUniversity, hospital or other
- Collaborators
- National Institute of Mental Health (NIMH)
- Study start
- Apr 2013
- Primary completion
- Jan 2016 (actual)
- Study completion
- May 2016 (actual)
- First posted
- 15 Apr 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Voluntary and involuntary attention processes are thought to play an important role in the development and maintenance of anxiety disorders including OCD. Individuals with OCD pay greater attention to threat information related to their illness and have difficulty shifting their attention from such triggers. Studies suggest that a change in attention bias may lead to a change in anxiety vulnerability. However, few studies have directly examined the causal role of attention bias in the maintenance of anxiety underlying OCD and whether modification of such biases may reduce pathological anxiety symptoms particularly in children. In this proposal, we aim to translate basic findings from research on cognitive biases in anxiety into a novel computerized intervention for child Obsessive Compulsive Disorder (OCD). The treatment is designed to target a basic cognitive vulnerability in OCD, namely the selective processing of threatening OCD-related information. 52 children with OCD will be randomly assigned to either a 12-session attention modification program (AMP) or an attention control condition (ACC). Clinical assessment of symptom severity along with a brief neurocognitive battery will be conducted before and after treatment. We hypothesize that children in the AMP group at end of treatment will show (1) decreased attention bias to OCD-related triggers using an independent measure of attention bias to assess change and (b) reduced OCD severity. This study is an initial step towards demonstrating the feasibility and efficacy of a novel computerized attention training program for OCD that ultimately may prove to be a highly transportable and accessible intervention for this childhood psychiatric disorder. Furthermore, the project will also examine neurocognitive performance before and after attention training to elucidate possible predictors and mechanisms of treatment response.
Detailed description
In this proposal, we aim to translate basic findings from research on cognitive biases in anxiety into a novel computerized intervention for child OCD. The treatment is designed to target a basic cognitive vulnerability in OCD, namely the selective processing of threatening OCD-related information. Briefly, the computerized procedure involves repeatedly redirecting participants' attention away from OCD-relevant threat cues in order to induce selective processing of neutral (non-threat) stimuli. This study is an initial step towards demonstrating the efficacy of a potentially highly transportable and accessible intervention for OCD. Furthermore, the project will also examine neurocognitive performance before and after attention modification to elucidate possible predictors and mechanisms of treatment response.
Aim 1: To examine the preliminary efficacy of a 12-session computerized attention modification program (AMP) on attention bias and symptom severity in children with OCD.
Hypothesis 1a: AMP treatment compared to the attention control condition (ACC) will be associated with a decrease in attention bias towards threat-cues in youth with OCD.
Hypothesis 1b: AMP treatment will be associated with a decrease in OCD symptom severity among OCD youth as measured by clinician-administered diagnostic interview and symptom rating scales.
Aim 2: To examine the changes in neurocognitive status over the course of treatment with AMP in children and adolescents with OCD.
Hypothesis 2: Those children who respond to AMP will exhibit improved performance on relevant neurocognitive measures at post-treatment.
Aim 3: To examine the relationship between baseline neurocognitive status and response to AMP.
Hypothesis 3: Baseline neurocognitive performance will be associated with greater AMP-related improvement in symptom severity among youth with OCD.
Exploratory Aim: To investigate the potential relationship between AMP and changes in behavioral and electrophysiological (EEG) correlates of cognitive control and affect regulation before and after treatment with AMP or ACC. The objective is to examine the feasibility, acceptability and suitability of using Error-Related Negativity (ERN), an evoked response potential (ERP) generated from cognitive activation paradigms assessing action-monitoring and conflict resolution under neutral and emotional contexts, to elucidate potential neural mechanisms underlying treatment. Although not powered for formal tests of mediation, we will explore in a preliminary fashion whether these neural indices may serve as potential biomarkers for pediatric OCD as well as predictors/mediators of treatment response.
Preliminary hypotheses: 1) Youth with OCD will be characterized by high amplitude ERN, which will not change with treatment; 2) AMP treatment will be associated with changes in EEG reflecting greater engagement of top-down (as indexed by the P3 component) versus bottom-up (indexed by the P1/N1 components) neural processes, particularly among children who exhibit improved performance on cognitive control tasks; 3) Baseline executive functioning in interference control and action monitoring will be associated with greater AMP-related improvement in OCD severity; 4) We will also explore the relationships of key variables such as trait anxiety, self-reported attention control, baseline OCD symptom severity and attention bias with each other and with response to AMP.
OCD is a chronic and often disabling psychiatric condition, affecting 2-4% of children and adolescents1. In the absence of effective treatment, it is often associated with considerable social, academic and familial impairment along with considerable psychiatric comorbidity including Tourette's and other Chronic Tic Disorders. Although a number of empirically supported treatments, both behavioral and pharmacological, exist for OCD, many children and their families are either not able to adequately access these treatments or derive only partial benefit from them. Thus, it is of critical importance to expand treatment options and develop more effective treatments that have the potential to be widely accessible to children suffering from OCD.
One etiological model of OCD proposes that symptoms arise from the abnormal processing of threat-relevant information. According to this model, selective attention to threatening information heightens anxiety and anxiety-related avoidance of the perceived threat, and the avoidance behaviors, in turn, prevent disconfirmation of fear-related beliefs and serves to maintain anxiety. Thus, attention bias towards threat may be causally related to the behavioral avoidance of the perceived threat. Research indicates that attention bias towards OCD related material ameliorates after effective cognitive behavioral therapy, thus highlighting that attention bias is malleable. Nevertheless, the critical question remains whether a reduction in attention bias causes a reduction in OCD symptoms or whether attention bias is an epiphenomenon of the symptoms. Recently, studies have begun to directly manipulate attention bias to address this question. In one such study, attention was trained in adults with OCD contamination fears by building a contingency between the locations of the OCD-related word in the active condition and not in the control condition on a modified dot-probe task. Participants in the attention training group showed significant reductions in both attention bias for threat and OCD symptom severity. The extension of this research to clinical patient and child samples with a multi-session treatment protocol has yet to be conducted. To date, no study has investigated attention training in children with OCD, although there are data to suggest positive results in adults with OCD as well as Social Phobia and Generalized Anxiety Disorder.
A number of recent studies have demonstrated that the willful direction of attention in the presence of threatening stimuli activates prefrontal regions thought to be involved in attention control, which in turn appears to down-regulate activation of the amygdala, a structure involved in the emotional processing of fear/threat stimuli. Many of these tasks have involved techniques like cognitive reappraisal or altering cognitive processing of threatening. The question remains whether similar neurobiological mechanisms underlie the effects of attention training. Given the importance of higher-level attention control in reducing biased attention processing and dampening anxious states, helping anxious individuals improve attention control may be an important mechanism for reducing the negative impact and development of psychopathology. In an attempt to gather preliminary data on the possible neurocognitive predictors and mechanisms of treatment response, we also plan to assess aspects of response inhibition and memory/learning that have been implicated in neurocognitive studies of OCD before and after treatment with AMP.
We hypothesize that training attention away from OCD-related threat stimuli will decrease attention bias towards the threat and based on the assumption that attention bias is causally related to anxiety symptoms, this decrease in bias would lead to a decrease in avoidance of threatening stimuli. More specifically, we predict that compared to the control condition (ACC), AMP will decrease attention bias towards the threat and facilitate behavioral approach towards the feared stimuli in children with OCD along with an overall decrease in their symptom severity.
The present study focuses on children and adolescents for two important reasons. First, OCD typically onsets in childhood, and enhanced understanding of the neuro-developmental correlates of OCD and mechanisms underlying treatment at this age has the potential to prevent long-term morbidity. Second, the focus on this age group allows us to study the disorders prior to the development of significant secondary psychiatric and psychosocial morbidity, which commonly accompanies OCD in adulthood. Thus far, only limited research on the effects of attention modification training on OCD severity has been conducted in children. This study may generate significant new information concerning the neurocognitive underpinnings of OCD, the commonality of these underpinnings to other neurodevelopmental disorders of childhood, and the neurocognitive correlates of response to a potentially new and relatively accessible nonpharmacological treatment intervention. This knowledge will be used to develop more effective treatments with an eye towards matching interventions to specific individuals on the basis of characteristic pre-treatment cognitive profiles.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Attention Modification Program | Experimental | Behavioral: Attention Modification ProgramActive computer-based attention training treatment designed to directly but implicitly modify biased attention patterns in anxious patients in service of symptom relief. AMP is a modified version of the dot-probe paradigm similar to the original task used by MacLeod, Mathews, and Tata. This paradigm has been modified to facilitate an attention bias away from threatening material. In this case, the probe always replaces the neutral word. |
| Attention Control Condition | Placebo comparator | Behavioral: Attention Control ConditionControl computer-based attention training task, which is not designed to modify biased attention patterns in anxious patients. ACC is a modified version of the dot-probe paradigm similar to the original task used by MacLeod, Mathews, and Tata. In this case, the probe randomly replaces the neutral word or the threat word. |
Who may qualify
- Ages
- 8 to 17 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (5 listed)
- Age 8-17 (inclusive) at the time of initial evaluation
- Subject meets Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) diagnostic criteria for OCD.
- Unmedicated or on stable medication treatment for anxiety, OCD, attention deficit hyperactivity disorder, tics, and/or depressive disorder for at least 6 weeks prior to study entry, with no planned changes for duration of study participation.
- Child is fluent English speaker.
- Parental informed consent and child informed assent must be completed. Parents must agree to their child's participation in this protocol.
Key exclusion criteria (4 listed)
- Intelligence Quotient < 80 on Wechsler Abbreviated Scale of Intelligence (WASI).
- Excessive or problematic substance use as reported per initial telephone screening, or DSM-IV Conduct Disorder within the past 3 months.
- Subject has a lifetime DSM-IV diagnosis of pervasive developmental disorder, Mania, or Psychotic Disorder.
- Subject has any serious psychiatric, psychosocial, or neurological condition (i.e., attention deficit hyperactivity disorder, major depressive disorder, anxiety, anxiety, severe aggression, family discord) requiring immediate treatment other than that provided in the current study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Attention Modification ProgramAlso: AMP, attention bias modification, attention trainingEach trial begins with a fixation cross presented in the center of the computer screen for 500 ms. The cross is then replaced by a word pair presented in the center of the screen for 500 ms. The word pair disappears and a probe (i.e., the letter "E" or "F") appears immediately in the location of one of the two words. Participants will be instructed to decide whether the letter is an E or an F and press the corresponding mouse button. This paradigm has been modified to facilitate an attention bias away from threatening material. In this case, the probe always replaces the neutral word. Thus, although there will be no specific instruction to direct attention away from the threat word, on all trials, the position of the neutral word will indicate the position of the probe. | Behavioural | Attention Modification Program |
| Attention Control ConditionAlso: ACCEach trial begins with a fixation cross presented in the center of the computer screen for 500 ms. The cross is then replaced by a word pair presented in the center of the screen for 500 ms. The word pair disappears and a probe (i.e., the letter "E" or "F") appears immediately in the location of one of the two words. Participants will be instructed to decide whether the letter is an E or an F and press the corresponding mouse button. This paradigm is not intended to facilitate an attention bias away from threatening material. In this case, the probe randomly replaces the threat or neutral word. | Behavioural | Attention Control Condition |
Primary outcome
Clinical Global Impression-Severity (CGI-S) and Improvement (CGI-I) Scales Change From Pre-Treatment to Post-Treatment
Time frame: pre-treatment (week 0) and post-treatment (week 5)
Clinical Global Impression-Severity (CGI-S) and Improvement (CGI-I) Scales. The CGI-S and CGI-I are clinician-rated scales used in clinical trials for over 25 years. Participants receiving a post-treatment CGI-I score of 1 (very much improved) or 2 (much improved) on this one-item, 7-point rating will be considered treatment responders.
2 secondary outcomes
Children's Yale-Brown Obsessive Compulsive Scale Change From Pre-Treatment to Post-Treatment
Time frame: pre-treatment (week 0) and post-treatment (week 5)
Attention Bias Assessment Change from Pre-Treatment to Post-Treatment
Time frame: pre-treatment (week 0) and post-treatment (week 5)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jan 2017.
- Individual participant dataSharing planned: No
Related trials for Obsessive Compulsive Disorder
Not yet recruitingObservational study
Investigation of Obsessive-Compulsive Disorder in Patients With Elbow Epicondylitis
Lateral Epicondylitis, Medial Epicondylitis
Recruiting
Focused Ultrasound for Behavioral Health
Depression, Anxiety
Not yet recruiting
Linear Accelerator Radiosurgical Anterior Capsulotomy With Task-based fMRI Identification of PERSonalized and PrEdictiVE Biomarkers of REsponse in Treatment-Refractory Obsessive-Compulsive Disorder (PERSEVERE Trial)
Treatment-refractory Obsessive-compulsive Disorder (trOCD)
Recruiting
tDCS Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive Disorder
Obsessive-Compulsive Disorder
Recruiting
Mindfulness Intervention for Psychological and Family Dynamics in Children With Body-Focused Repetitive Behaviors
Mindfulness Skills, Psychosocial Education
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Susanna Chang, PhD principal investigator
University of California, Los Angeles
John Piacentini, PhD principal investigator
University of California, Los Angeles
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Attention Modification Program in people with Obsessive Compulsive Disorder, run by University of California, Los Angeles at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Jan 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Clinical Global Impression-Severity (CGI-S) and Improvement (CGI-I) Scales Change From Pre-Treatment to Post-Treatment (time frame: pre-treatment (week 0) and post-treatment (week 5)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2017.